AI
EBS icon

Analytic Investors’s Emergent Biosolutions EBS Stock Holding History

Analytic Investors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$773K Buy
+24,509
New +$712K 0.01% 410
2014
Q4 		– Sell
-21,180
Closed -$451K – 555
2014
Q3 		$451K Sell
21,180
-2,389
-10% -$54.7K 0.01% 468
2014
Q2 		$529K Buy
+23,569
New +$549K 0.01% 405

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Analytic Investors's EBS Position: Q3 2016 in Review

Analytic Investors opened a new position in Emergent Biosolutions (EBS) in Q3 2016: 24,509 shares worth $773K. The stake represents 0.01% of the portfolio and ranks #410 among its holdings. This is a return to the name: Analytic Investors previously reported a position in EBS as recently as Q3 2014.

Analytic Investors first reported a position in EBS in Q2 2014 and has held it in 3 quarters since. 204 funds tracked by Wall St. Rank hold EBS as of Q3 2016.

  • Analytic Investors held 24,509 shares of Emergent Biosolutions worth $773K as of Q3 2016.
  • Emergent Biosolutions was a new Analytic Investors position in Q3 2016.
  • Emergent Biosolutions made up 0.01% of Analytic Investors's portfolio in Q3 2016, its #410 holding.
  • Analytic Investors first reported a position in Emergent Biosolutions in Q2 2014 and has held it in 3 quarters since.
  • 204 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.